The intersection of two pandemics: COVID-19 and dementia
COVID-19 disproportionately impacted older adults who are also at risk for more severe outcomes and extended stays in hospitals. The stay-at-home orders around the country and no-visitor policies implemented in many retirement communities and nursing homes also impacted older adults who rely on additional outside assistance for socialization and medical care. These lockdowns, shutdowns, and extended isolated hospital stays all impact the cognitive function of older adults, leading researchers to believe there may be an increase in dementia in these older adults in future years. Join Bryan James, PhD, as he discusses how isolation allows the cognitive research capacity to change, leading to higher risk of dementia and Alzheimer’s disease.
Bryan James, PhD, is an epidemiologist at the Rush Alzheimer’s Disease Center (RADC) and Associate Professor in the Department of Internal Medicine, Section of Epidemiology Research, at the Rush University Medical Center. His research focuses on the neuroepidemiology of Alzheimer’s disease and other conditions of aging. This includes determining how social and behavioral determinants and medical encounters contribute to cognitive decline and dementia, as well as describing the societal impact of dementia. His recently concluded K01 studied the link between hospitalization and cognitive decline in older patients. James has contributed to the Alzheimer's Association Annual Facts & Figures Report since 2010. He is the host of Epidemiology Counts, the official podcast of the Society for Epidemiologic Research, and is a social media editor for the American Journal of Epidemiology. He received his PhD from the Johns Hopkins Bloomberg School of Public Health in 2009.